GlassScriptPhysician profile
John Griffith Erickson
NPI 1336589662
$5,276.99
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,183 · 2020: $51.72 · 2021: $235 · 2022: $154 · 2023: $408 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.80 |
| Travel and Lodging | $234.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $1,266.57 | 2019-2023 | |
| Medical Device Business Services, INC. | $1,168.73 | 2019 | |
| Arthrex, INC. | $1,160.77 | 2019-2023 | |
| Smith+Nephew, INC. | $443.37 | 2019-2022 | |
| Stryker Corporation | $350.91 | 2019-2025 | Augment Injectable, Prophecy, Ortholoc 2 Lapifuse |
| Depuy Synthes Sales INC. | $343.64 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $226.62 | 2019-2021 | |
| Acera Surgical, INC. | $140.80 | 2019 | |
| Misonix INC | $77.29 | 2019-2020 | |
| Organogenesis INC. | $55.38 | 2022-2023 | Affinity |
| Heron Therapeutics, INC. | $15.57 | 2021 | |
| Convatec INC. | $14.19 | 2020 | |
| Osiris Therapeutics INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.